Europe’s medicines watchdog, namely the European Medicines Agency (EMA) on Thursday said it will start reviewing the Russian-made Sputnik V vaccine for Coronavirus,
The decision by EMA’s human medicines committee (CHMP) “is based on results from laboratory studies and clinical studies in adults. These studies indicate that Sputnik V triggers the production of antibodies and immune cells that target the SARS-CoV-2 coronavirus and may help protect against COVID-19,” the Amsterdam-based agency …
This story is part of New Europe’s Premium content.
| To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑ |
In this article:
